Thalia buys Sanmirna, becomes a clinical-stage RNA company
Why it matters: The deal accelerates Thalia’s development timeline by several years and gives the company a clinical-stage asset. It ...
Tag: M&A
Why it matters: The deal accelerates Thalia’s development timeline by several years and gives the company a clinical-stage asset. It ...